Deferoxamine Mesylate and Hydrocodone Extended-Release Capsules
Determining the interaction of Deferoxamine Mesylate and Hydrocodone Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: deferoxamine
Brand name: Desferal
Synonyms: Deferoxamine
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Deferoxamine Mesylate-Hydrocodone Extended-Release Tablets
- Deferoxamine Mesylate-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Deferoxamine Mesylate-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Deferoxamine Mesylate-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Deferoxamine Mesylate-Hydrocortisone
- Deferoxamine Mesylate-Hydrocortisone (Systemic)
- Hydrocodone Extended-Release Capsules-Defibrotide
- Hydrocodone Extended-Release Capsules-Defibrotide Intravenous
- Hydrocodone Extended-Release Capsules-Defibrotide Sodium
- Hydrocodone Extended-Release Capsules-Definity
- Hydrocodone Extended-Release Capsules-Defitelio
- Hydrocodone Extended-Release Capsules-Deflazacort